首页>
外国专利>
PREPARATION FOR PREVENTING CALCIUM-OXALATE URATE BASED URINARY CALCULI
PREPARATION FOR PREVENTING CALCIUM-OXALATE URATE BASED URINARY CALCULI
展开▼
机译:预防基于草酸钙的尿酸钙计算
展开▼
页面导航
摘要
著录项
相似文献
摘要
The preparation for preventing the repeated occurrence of calcium-oxalate and urate based urinary calculi consists of crystallization inhibitors: magnesium, citrate, bicarbonate and vitamin B6. The maximum daily dose of the individual crystallisation inhibitor in the preparation is: potassium citrate up to 40.8 g/day, sodium bicarbonate up to 24.8 g/day (in the case of joint use of citrate and bicarbonate the quantity may not exceed 3 mmol/kg of the patient's body weight), magnesium glucuronate up to 51.4 g/day and vitamin B6 up to 200 mg/day.
展开▼
机译:防止草酸钙和尿酸基尿结石重复出现的制剂由结晶抑制剂组成:镁,柠檬酸,碳酸氢盐和维生素B6。制剂中单个结晶抑制剂的最大日剂量为:柠檬酸钾,最高40.8 g /天,碳酸氢钠,最高24.8 g /天(在柠檬酸盐和碳酸氢盐联合使用的情况下,其量不得超过3 mmol /公斤体重),葡萄糖醛酸镁每天最多51.4克和维生素B6每天最多200毫克。
展开▼